id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-P-0408-0005,FDA,FDA-2003-P-0408,"Letter from FDA CDER to Olsson, Frank and Weeda, PC",Other,LET-Letter,2004-03-11T05:00:00Z,2004,3,2004-03-08T05:00:00Z,,2024-10-22T21:03:34Z,,0,0,09000064804a1b0a
FDA-2003-P-0408-0004,FDA,FDA-2003-P-0408,FDA Notice of Determination,Notice,N-Notice,2004-03-08T05:00:00Z,2004,3,2004-03-05T05:00:00Z,2004-03-09T04:59:59Z,2024-10-22T20:51:07Z,69FR10711,0,0,09000064804a1b09